D D Bigner

2.5k total citations
24 papers, 1.3k citations indexed

About

D D Bigner is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, D D Bigner has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Neurology. Recurrent topics in D D Bigner's work include Glioma Diagnosis and Treatment (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Neuroblastoma Research and Treatments (6 papers). D D Bigner is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Neuroblastoma Research and Treatments (6 papers). D D Bigner collaborates with scholars based in United States, China and Norway. D D Bigner's co-authors include Michael R. Zalutsky, Peter A. Humphrey, Sandra H. Bigner, Henry S. Friedman, H. S. Friedman, Joachim Mark, Bert Vogelstein, Albert J. Wong, Rolf Bjerkvig and Ole Didrik Lærum and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

D D Bigner

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D D Bigner United States	19	461	423	412	399	235	24	1.3k
Noriaki Sugawa Japan	8	544 1.2×	331 0.8×	187 0.5×	470 1.2×	219 0.9×	13	1.1k
Ilkcan Cokgor United States	12	277 0.6×	404 1.0×	322 0.8×	213 0.5×	188 0.8×	18	880
Xiang-Dong Ji United States	5	1.0k 2.2×	450 1.1×	298 0.7×	754 1.9×	282 1.2×	5	1.8k
H-J. Su Huang United States	8	591 1.3×	327 0.8×	192 0.5×	546 1.4×	178 0.8×	8	1.1k
Elizabeth Cohen‐Jonathan Moyal France	17	328 0.7×	508 1.2×	240 0.6×	306 0.8×	255 1.1×	50	1.1k
J.-C. Tonn Germany	15	541 1.2×	724 1.7×	207 0.5×	196 0.5×	318 1.4×	23	1.4k
A. O’Neill United States	12	415 0.9×	579 1.4×	178 0.4×	495 1.2×	280 1.2×	26	1.4k
An Claes Netherlands	13	548 1.2×	503 1.2×	241 0.6×	354 0.9×	253 1.1×	17	1.3k
D D Bigner United States	10	369 0.8×	262 0.6×	278 0.7×	228 0.6×	148 0.6×	13	940
Markus J. Riemenschneider Germany	21	529 1.1×	738 1.7×	189 0.5×	195 0.5×	174 0.7×	59	1.5k

Countries citing papers authored by D D Bigner

Since Specialization

Citations

This map shows the geographic impact of D D Bigner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D D Bigner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D D Bigner more than expected).

Fields of papers citing papers by D D Bigner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D D Bigner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D D Bigner. The network helps show where D D Bigner may publish in the future.

Co-authorship network of co-authors of D D Bigner

This figure shows the co-authorship network connecting the top 25 collaborators of D D Bigner. A scholar is included among the top collaborators of D D Bigner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D D Bigner. D D Bigner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Lei, Junxia Zhang, Liang Zeng, et al.. (2014). AJAP1 is Dysregulated at an Early Stage of Gliomagenesis and Suppresses Invasion Through Cytoskeleton Reorganization. CNS Neuroscience & Therapeutics. 20(5). 429–437. 24 indexed citations

Han, Lei, Kailiang Zhang, Junxia Zhang, et al.. (2014). Abstract 1561: AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganization. Cancer Research. 74(19_Supplement). 1561–1561.

Ding, Dale, D D Bigner, Thomas J. Cummings, et al.. (2009). Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1. Journal of Neuro-Oncology. 98(1). 1–7. 40 indexed citations

Bacolod, Manny D., Sihan Lin, Scott A. Johnson, et al.. (2008). The Gene Expression Profiles of Medulloblastoma Cell Lines Resistant to Preactivated Cyclophosphamide. Current Cancer Drug Targets. 8(3). 172–179. 33 indexed citations

Jones, Lee W., et al.. (2006). Patterns of exercise across the cancer trajectory in brain tumor patients. Cancer. 106(10). 2224–2232. 28 indexed citations

Yamaguchi, Keisuke, Mark D. Richardson, D D Bigner, & Madan M. Kwatra. (2005). Signal transduction through substance P receptor in human glioblastoma cells: roles for Src and PKCδ. Cancer Chemotherapy and Pharmacology. 56(6). 585–593. 32 indexed citations

Boskovitz, Abraham, Gamal Akabani, Charles N. Pegram, D D Bigner, & Michael R. Zalutsky. (2004). Human/murine chimeric 81C6 F(ab′)2 fragment: preclinical evaluation of a potential construct for the targeted radiotherapy of malignant glioma. Nuclear Medicine and Biology. 31(3). 345–355. 11 indexed citations

Akabani, Gamal, Roger E. McLendon, D D Bigner, & Michael R. Zalutsky. (2002). Vascular targeted endoradiotherapy of tumors using alpha-particle-emitting compounds: theoretical analysis. International Journal of Radiation Oncology*Biology*Physics. 54(4). 1259–1275. 25 indexed citations

Akabani, Gamal, Craig J. Reist, Ilkcan Cokgor, et al.. (1999). Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors.. PubMed. 40(4). 631–8. 39 indexed citations

10.

Cleveland, Linda, et al.. (1998). Immunohistochemical detection of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in formalin-fixed, paraffin-embedded astrocytomas.. PubMed. 78(5). 643–4. 30 indexed citations

11.

Kurpad, Shekar N., M. Eileen Dolan, Roger E. McLendon, et al.. (1997). Intraarterial O 6 -benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemotherapy and Pharmacology. 39(4). 307–316. 22 indexed citations

12.

McCowage, Geoffrey, R D Tien, Roger E. McLendon, et al.. (1996). Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose Cyclophosphamide. Medical and Pediatric Oncology. 27(1). 32–39. 37 indexed citations

13.

Brown, Mark T., R. Edward Coleman, Allan H. Friedman, et al.. (1996). Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results.. PubMed. 2(6). 963–72. 74 indexed citations

14.

Schold, S. Clifford, James E. Herndon, P. C. Burger, et al.. (1993). Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma.. Journal of Clinical Oncology. 11(1). 77–83. 35 indexed citations

15.

Wikstrand, Carol J., Gregory N. Fuller, Sandra H. Bigner, et al.. (1991). Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas. Acta Neuropathologica. 82(1). 45–54. 48 indexed citations

16.

Lund‐Johansen, Morten, Rolf Bjerkvig, Peter A. Humphrey, et al.. (1990). Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro.. PubMed. 50(18). 6039–44. 189 indexed citations

17.

Zalutsky, Michael R., et al.. (1990). Monoclonal antibody and F(ab')2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration.. PubMed. 50(13). 4105–10. 49 indexed citations

18.

Bigner, Sandra H., Peter A. Humphrey, Albert J. Wong, et al.. (1990). Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.. PubMed. 50(24). 8017–22. 275 indexed citations

19.

Zalutsky, Michael R., et al.. (1989). Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies.. PubMed. 49(10). 2807–13. 119 indexed citations

20.

Zalutsky, Michael R., et al.. (1989). Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.. Proceedings of the National Academy of Sciences. 86(18). 7149–7153. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact